Good distribution practice

Falsified Medicines and the supply chain

Posted by: Tracy Moore, Posted on: 8 August 2019 - Categories: Compliance matters, Good distribution practice, Good manufacturing practice, Wider MHRA

Sharing experience from recent events to help you safeguard the legitimate supply chain and avoid risks to public health

How the implementation of Safety Features progresses 5 months in

Posted by: Tracy Moore, Posted on: 5 July 2019 - Categories: Compliance matters, Good distribution practice, Good manufacturing practice, Wider MHRA

The definition of a falsified medicine and how to check that your systems comply

The 2018 Good Distribution Practice (GDP) Symposium

Posted by: Bernadette Wilson, Posted on: 11 June 2019 - Categories: Compliance matters, Events and symposia, Good distribution practice

Maintaining compliance in a changing world and the complementary themes of change management and control ran throughout the various sessions at this event.

PIC/S Meetings April 2019

Posted by: Mark Birse, Posted on: 21 May 2019 - Categories: Compliance matters, Events and symposia, Good clinical practice, Good distribution practice, Good manufacturing practice, Good pharmacovigilance practice

From 8 to 10 April 2019, the Pharmaceutical Inspection Co-operation Scheme (PIC/S) Committee and PIC/S Executive Bureau meetings took place in Geneva, Switzerland.

What does qualification of suppliers mean to you? Risks to patients and to your business

Posted by: Peter Brown, Posted on: 8 May 2019 - Categories: Compliance matters, Good distribution practice, Good manufacturing practice

Recent cases of criminal attempts to sell falsified and stolen stock into the legitimate supply chain have exposed weaknesses in some supplier qualification processes. A reminder of what companies need to do to protect themselves, the public and the supply chain.

Introducing the GDP Office Based Evaluation and Risk Assessment programme (OBERA)

Posted by: Cheryl Blake, Posted on: 16 April 2019 - Categories: Compliance matters, Good distribution practice

Gateway inspections are due to commence spring 2019 as the first stage of a new GDP inspection approach which will allow MHRA to increase its level of oversight whilst reducing the regulatory burden on those companies with a large number of sites which perform reduced or limited levels of GDP activity.